4/29
08:54 am
teva
Earnings Snapshot: Teva Pharmaceutical Industries tops Q1 estimates; maintains 2026 business outlook [Seeking Alpha]
Low
Report
Earnings Snapshot: Teva Pharmaceutical Industries tops Q1 estimates; maintains 2026 business outlook [Seeking Alpha]
4/29
07:57 am
teva
Medincell - UZEDY®: Q1 2026 Net Sales Reached $63M, Up 62% Year-on-Year [Yahoo! Finance]
Low
Report
Medincell - UZEDY®: Q1 2026 Net Sales Reached $63M, Up 62% Year-on-Year [Yahoo! Finance]
4/29
07:39 am
teva
Medincell - UZEDY®: Q1 2026 Net Sales Reached $63M, Up 62% Year-on-Year
Low
Report
Medincell - UZEDY®: Q1 2026 Net Sales Reached $63M, Up 62% Year-on-Year
4/29
07:00 am
teva
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
Medium
Report
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
4/29
06:38 am
teva
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva's Pivot to Growth Strategy [Yahoo! Finance]
Medium
Report
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva's Pivot to Growth Strategy [Yahoo! Finance]
4/29
06:30 am
teva
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Medium
Report
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
4/28
06:00 pm
teva
Here are the major earnings before the open Wednesday [Seeking Alpha]
Medium
Report
Here are the major earnings before the open Wednesday [Seeking Alpha]
4/27
10:20 pm
teva
Teva Pharmaceutical's Turnaround Is Working. Here's When to Buy the Stock. [Globe and Mail, The (Toronto, Canada)]
Low
Report
Teva Pharmaceutical's Turnaround Is Working. Here's When to Buy the Stock. [Globe and Mail, The (Toronto, Canada)]
4/27
07:32 am
teva
Teva honored for gender equality as women reach 43% of senior management in Israel [Yahoo! Finance]
Low
Report
Teva honored for gender equality as women reach 43% of senior management in Israel [Yahoo! Finance]
4/23
09:37 am
teva
Is It Too Late To Consider Teva (TEVA) After Its 118% One Year Share Price Surge? [Yahoo! Finance]
Low
Report
Is It Too Late To Consider Teva (TEVA) After Its 118% One Year Share Price Surge? [Yahoo! Finance]
4/22
06:08 am
teva
Teva Pharmaceutical Industries (TEVA) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Low
Report
Teva Pharmaceutical Industries (TEVA) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
4/19
09:52 am
teva
Teva Pharmaceutical Industries Limited (TEVA): David Einhorn Trims Holding [Yahoo! Finance]
Low
Report
Teva Pharmaceutical Industries Limited (TEVA): David Einhorn Trims Holding [Yahoo! Finance]
4/18
05:40 am
teva
3 Catalysts That Could Send Teva Stock to $40 and Beyond [Globe and Mail, The (Toronto, Canada)]
Low
Report
3 Catalysts That Could Send Teva Stock to $40 and Beyond [Globe and Mail, The (Toronto, Canada)]
4/16
09:33 pm
teva
How Teva Pharmaceutical Industries (TEVA) Story Is Shifting With Duvakitug R&D And Biosimilars [Yahoo! Finance]
Medium
Report
How Teva Pharmaceutical Industries (TEVA) Story Is Shifting With Duvakitug R&D And Biosimilars [Yahoo! Finance]
4/15
08:00 am
teva
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
Low
Report
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
4/14
08:00 am
teva
Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics
Low
Report
Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics
4/13
08:56 pm
teva
Teva: The Market Is Pricing The Past, Not The Pipeline - Initiating Buy [Seeking Alpha]
Low
Report
Teva: The Market Is Pricing The Past, Not The Pipeline - Initiating Buy [Seeking Alpha]
4/9
12:18 pm
teva
Teva Pharmaceutical Industries (TEVA) had its price target raised by Bank of America Corporation from $38.00 to $42.00. They now have a "buy" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (TEVA) had its price target raised by Bank of America Corporation from $38.00 to $42.00. They now have a "buy" rating on the stock.
4/8
04:01 pm
teva
Teva Pharmaceutical Industries Limited (TEVA): Billionaire Stan Druckenmiller Trims Position [Yahoo! Finance]
Low
Report
Teva Pharmaceutical Industries Limited (TEVA): Billionaire Stan Druckenmiller Trims Position [Yahoo! Finance]
4/1
05:27 pm
teva
PONLIMSI Biosimilar Approval and Xolair Filings Could Be A Game Changer For Teva Pharmaceutical Industries (TEVA) [Yahoo! Finance]
Low
Report
PONLIMSI Biosimilar Approval and Xolair Filings Could Be A Game Changer For Teva Pharmaceutical Industries (TEVA) [Yahoo! Finance]
3/30
09:55 am
teva
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) [Yahoo! Finance]
Low
Report
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) [Yahoo! Finance]
3/30
08:00 am
teva
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Low
Report
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
3/30
05:45 am
teva
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Sharp One Month Share Price Pullback [Yahoo! Finance]
Low
Report
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Sharp One Month Share Price Pullback [Yahoo! Finance]
3/19
04:45 pm
teva
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 [Yahoo! Finance]
Low
Report
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 [Yahoo! Finance]
3/19
04:30 pm
teva
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
Medium
Report
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026